| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,399 |
12,220 |
$501K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,769 |
4,382 |
$234K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,354 |
4,917 |
$215K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,982 |
3,731 |
$203K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,643 |
2,441 |
$88K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,435 |
3,471 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,617 |
8,165 |
$54K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
681 |
601 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
738 |
689 |
$20K |
| 87807 |
|
300 |
299 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
225 |
207 |
$2K |
| 81002 |
|
789 |
686 |
$1K |
| 81025 |
|
109 |
108 |
$305.22 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
56 |
50 |
$36.95 |